The Marshall Protocol Study Site Home




Search by username
   Not logged in - Login | Register 

Interested how Europe funds its health research?
 Moderated by: Prof Trevor Marshall

New Topic


Prof Trevor Marshall
Foundation Staff

Joined: Fri Jul 9th, 2004
Location: Thousand Oaks, California USA
Posts: 16174
Status:  Offline
 Posted: Mon Oct 14th, 2013 05:12


I have just posted a video of the keynote speech from the recent EPMA Summit and Conference. For those of you who are interested in regulatory and FDA/NIH approval pathways, it is worth taking a look at the much warmer relationships between research and regulators in Europe.

Irene Norstedt has spent 11 years pushing forward the IMI project, where the EU and Industry each pay 50% of new research aimed at discovering and testing new drugs. She now heads the Personalised Medicine unit in the EU, which clearly has a very high profile. By way of contrast, there has been no progress to advance PPPM (Predictive, Preventative and Personalized Medicine) here in the USA, although an initial conference has been scheduled for next year.

The term 'Personalized medicine' in the USA typically means figuring out which people will not respond properly to current (ineffective and dangerous) drug therapies. That is not what PPPM is all about...

Here is the video, I trust you enjoy watching it. The talk lasts for 30 minutes, followed by questions.

Please don't overlook the video of my own presentation at the special EPMA Summit in the EU Parliament (which I posted last week):


 Current time is 21:22

* We can help you understand chronic disease, but only your physician is licensed to give you medical care *

Powered by WowBB 1.7 - Entire site Copyright © 2004-2020 Autoimmunity Research Foundation, All Rights Reserved
Click here to view our PRIVACY POLICY
Page processed in 0.0498 seconds (75% database + 25% PHP). 17 queries executed.